Sara Petronilho
Overview
Explore the profile of Sara Petronilho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
54
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petronilho S, Poullot E, Andre A, Robe C, Nouhoum S, Fataccioli V, et al.
Am J Surg Pathol
. 2025 Jan;
49(3):273-283.
PMID: 39758028
Lymphomas of T-follicular helper origin (T-follicular helper-cell lymphoma [TFHL]) are often accompanied by an expansion of B-immunoblasts, occasionally with Hodgkin/Reed-Sternberg-like (HRS-like) cells, making the differential diagnosis with classic Hodgkin lymphoma...
2.
Petronilho S, Gournay V, Tauziede-Espariat A, Pina H, Pecriaux A, Drieux F, et al.
Histopathology
. 2022 Mar;
80(7):1128-1130.
PMID: 35238057
No abstract available.
3.
Petronilho S, Sequeira J, Paulino S, Lopes P, Lisboa S, Chacim S, et al.
J Pers Med
. 2021 Dec;
11(12).
PMID: 34945856
Background: DLBCL represent a heterogeneous group of aggressive diseases. High grade B-cell lymphomas (HGBCL) were recently individualized from DLBCL as a discrete diagnostic entity due to their worse prognosis. Currently,...
4.
Salta S, Maia-Moco L, Estevao-Pereira H, Sequeira J, Vieira R, Bartosch C, et al.
Int J Cancer
. 2021 Aug;
149(11):1916-1925.
PMID: 34460099
Cervical cancer remains a health concern. Effective screening programs are critical to reduce the incidence and mortality. High-risk HPV (hr-HPV) testing as primary screening tool discloses high sensitivity but suboptimal...
5.
Silva-Oliveira R, Pereira F, Petronilho S, Martins A, Lameirinhas A, Constancio V, et al.
J Clin Med
. 2020 Dec;
9(12).
PMID: 33276477
Background: trastuzumab is considered the standard of care for human epidermal growth factor receptor-2 (HER-2+) breast cancer patients. Regardless of the benefits of its use, many early-stage patients eventually recur,...
6.
Costantini M, Amoreo C, Torregrossa L, Ali G, Munari E, Jeronimo C, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33198197
Collecting duct carcinoma (CDC) is rare and aggressive histology of kidney cancers. Although different therapeutic approaches have been tested, the 2-year survival remains very poor. Since CDC exhibits overlapping features...
7.
Lobo C, Costa J, Petronilho S, Monteiro P, Leca L, Schmitt F
Diagn Cytopathol
. 2020 Apr;
49(5):596-605.
PMID: 32339444
Background: Cytological analysis is part of the initial etiological evaluation of serous effusions. The newly proposed International System for Reporting Serous Fluid Cytopathology (ISRSFC) aims to standardize reporting. Methods: All...
8.
Lobo J, Petronilho S, Newell A, Coach J, Harlow G, Cruz A, et al.
Mod Pathol
. 2019 Jun;
32(11):1574-1586.
PMID: 31231125
Breast cancer is a heterogeneous disease and additional biomarkers for individually predicting patient outcomes are needed. Aberrant membrane E-cadherin immunoexpression has been demonstrated in lobular breast cancer. Also, E-cadherin nuclear...
9.
Jorge J, Petronilho S, Alves R, Coucelo M, Goncalves A, Nascimento Costa J, et al.
Invest New Drugs
. 2019 Jun;
38(2):369-377.
PMID: 31147807
Splicing of pre-mRNA into functional mRNA, carried out by the spliceosome, represents a crucial step in eukaryotic gene expression. Mutations and other deregulation in some of the spliceosome components have...